All Vaccinology articles – Page 21
-
NewsCovid-19 jab shows no serious side effects in young children
A review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children - most of them aged 4 and younger - found no indications of serious side effects.
-
NewsTeam founds AI-powered vaccine library to prevent future pandemics
A research project to develop novel antigen designs will focus on 10 known virus families to build the ‘vaccine library’, using the computer-based Rosetta platform.
-
NewsTest tube immune system IDs protein candidates for HIV vaccine
Scientists have developed a technique to find protein fragments that best stimulate the immune system to recognize and attack the virus.
-
NewsDeadly virus structures pinpoint new targets for Lassa vaccine design
By comparing the structures of protein complexes from different lineages of the dangerous Lassa virus, a research team has identified new antibodies and vaccine targets.
-
NewsNew vaccine boosts hopes of eliminating meningitis across Africa
A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal bacteria: A, C, W, Y and X.
-
NewsUK launches 10-year science strategy to save lives and boost prosperity
The UK Health Security Agency (UKHSA) has launched a ten-year Science Strategy, setting out how UKHSA’s science can save more lives, secure health and prosperity and contribute to the UK’s ambition to be a global science superpower.
-
NewsClinical trial of mRNA universal influenza vaccine candidate begins
A clinical trial of an experimental universal influenza vaccine, H1ssF-3928 mRNA-LNP, has begun enrolling volunteers to test for safety and its ability to induce an immune response.
-
FeaturesA new frontier in Zika vaccine development
A milestone achievement for science in combating the Zika virus as a new vaccine trial begins in the UK.
-
NewsAlgorithm boosts Covid vaccine response 128-fold
Researchers have developed an AI algorithm that can rapidly design highly stable COVID-19 mRNA vaccine sequences that were previously unattainable, achieving a 128-fold increase in the vaccine’s antibody response.
-
NewsLiverpool begins first human trial of Zika vaccine
The first participant has received a dose of a new Zika virus vaccine being trialled by the University of Liverpool.
-
NewsBCG does not protect health workers against Covid
A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19.
-
NewsmRNA ingredient produced by biocatalytic synthesis
The new and patented method for the production of the important mRNA vaccine component pseudouridine is more efficient, sustainable and cost-effective than the previously used chemical synthesis.
-
NewsUK vaccine and food manufacturing hubs will save lives and cut carbon
Two initiatives, an investment of £24 million, will help the UK lead the world in preparedness for pandemics and epidemics, and in delivering secure food supplies.
-
NewsMore than 1 million lives saved across Europe by COVID-19 vaccines since the end of 2020
COVID-19 vaccination directly saved at least 1,004,927 lives across Europe between December 2020 and March 2023, according to new research being presented at ECCMID in Copenhagen, Denmark.
-
NewsNasal spray protects against coronavirus infection- including recent immune-evasive variants
Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus.
-
NewsResearchers develop world’s first mRNA vaccine for deadly bacteria
A team of researchers has developed an mRNA-based vaccine that is 100% effective against a type of bacteria that is lethal to humans.
-
NewsClinical trial finds temperature-stable TB vaccine is safe and prompts immune response
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system.
-
NewsHIV vaccine candidate aims to block virus before it takes root
The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.
-
NewsNew inoculation based on Ebola VSV vaccine concept protects macaques
Researchers have successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.
-
NewsNew vaccine targets life-threatening fungal infections
A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases.